Compile Data Set for Download or QSAR

Found 62 hits with Last Name = 'bloomquist' and Initial = 'we'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Alpha-1A adrenergic receptor (Rattus norvegicus (Rat))	BDBM85228 (N-(1-(2-((N-Methylsulfonyl)amino)ethyl)piperidin-4...) Show SMILES CC(C)n1nc(C(=O)NC2CCN(CCNS(C)(=O)=O)CC2)c2ccccc12 Show InChI InChI=1S/C19H29N5O3S/c1-14(2)24-17-7-5-4-6-16(17)18(22-24)19(25)21-15-8-11-23(12-9-15)13-10-20-28(3,26)27/h4-7,14-15,20H,8-13H2,1-3H3,(H,21,25)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Eli Lilly and Company Curated by PDSP Ki Database									J Med Chem 41: 1943-55 (1998) Article DOI: 10.1021/jm970857f BindingDB Entry DOI: 10.7270/Q26H4FZ3
					More data for this Ligand-Target Pair
Alpha-1A adrenergic receptor (Rattus norvegicus (Rat))	BDBM85226 (N-(2-(4-(1-Adamantylcarboxamido)-1-piperidinyl)eth...) Show SMILES CC(C)n1nc(C(=O)NCCN2CCC(CC2)C23CC4CC(CC(C4)C2)C3)c2ccccc12 |TLB:24:19:26:25.23.22,24:23:18.19.20:26,THB:22:21:18:25.23.24,22:23:18:21.20.26| Show InChI InChI=1S/C28H40N4O/c1-19(2)32-25-6-4-3-5-24(25)26(30-32)27(33)29-9-12-31-10-7-23(8-11-31)28-16-20-13-21(17-28)15-22(14-20)18-28/h3-6,19-23H,7-18H2,1-2H3,(H,29,33)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Eli Lilly and Company Curated by PDSP Ki Database									J Med Chem 41: 1943-55 (1998) Article DOI: 10.1021/jm970857f BindingDB Entry DOI: 10.7270/Q26H4FZ3
					More data for this Ligand-Target Pair
Alpha-1A adrenergic receptor (Rattus norvegicus (Rat))	BDBM85225 (N-(2-(4-((Benzyloxycarbonyl)amino)-1-piperidinyl)-...) Show SMILES CC(C)n1nc(C(=O)NCCN2CCC(CC2)NC(=O)OCc2ccccc2)c2ccccc12 Show InChI InChI=1S/C26H33N5O3/c1-19(2)31-23-11-7-6-10-22(23)24(29-31)25(32)27-14-17-30-15-12-21(13-16-30)28-26(33)34-18-20-8-4-3-5-9-20/h3-11,19,21H,12-18H2,1-2H3,(H,27,32)(H,28,33)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Eli Lilly and Company Curated by PDSP Ki Database									J Med Chem 41: 1943-55 (1998) Article DOI: 10.1021/jm970857f BindingDB Entry DOI: 10.7270/Q26H4FZ3
					More data for this Ligand-Target Pair
Alpha-1A adrenergic receptor (Rattus norvegicus (Rat))	BDBM85227 (N-(1-Benzylpiperidin-4-yl)-1-isopropylindazole-3-c...) Show SMILES CC(C)n1nc(C(=O)NC2CCN(Cc3ccccc3)CC2)c2ccccc12 Show InChI InChI=1S/C23H28N4O/c1-17(2)27-21-11-7-6-10-20(21)22(25-27)23(28)24-19-12-14-26(15-13-19)16-18-8-4-3-5-9-18/h3-11,17,19H,12-16H2,1-2H3,(H,24,28)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Eli Lilly and Company Curated by PDSP Ki Database									J Med Chem 41: 1943-55 (1998) Article DOI: 10.1021/jm970857f BindingDB Entry DOI: 10.7270/Q26H4FZ3
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50193804 ((S)-6-(4-(2-(3-(3-(2-cyclobutylethyl)-2-oxo-2,3-di...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CCC3)c12 Show InChI InChI=1S/C32H39N5O5/c1-32(2,17-22-9-12-25(13-10-22)42-28-14-11-23(18-34-28)30(33)39)35-19-24(38)20-41-27-8-4-7-26-29(27)37(31(40)36-26)16-15-21-5-3-6-21/h4,7-14,18,21,24,35,38H,3,5-6,15-17,19-20H2,1-2H3,(H2,33,39)(H,36,40)/t24-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50193801 ((S)-6-(4-(2-(3-(3-(2-cyclopentylethyl)-2-oxo-2,3-d...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CCCC3)c12 Show InChI InChI=1S/C33H41N5O5/c1-33(2,18-23-10-13-26(14-11-23)43-29-15-12-24(19-35-29)31(34)40)36-20-25(39)21-42-28-9-5-8-27-30(28)38(32(41)37-27)17-16-22-6-3-4-7-22/h5,8-15,19,22,25,36,39H,3-4,6-7,16-18,20-21H2,1-2H3,(H2,34,40)(H,37,41)/t25-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	2.40	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224024 (6-(4-(2-((S)-2-hydroxy-3-(3-isobutyl-2-oxoindolin-...) Show SMILES CC(C)CC1C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 |w:4.3| Show InChI InChI=1S/C31H38N4O5/c1-19(2)14-24-28-25(35-30(24)38)6-5-7-26(28)39-18-22(36)17-34-31(3,4)15-20-8-11-23(12-9-20)40-27-13-10-21(16-33-27)29(32)37/h5-13,16,19,22,24,34,36H,14-15,17-18H2,1-4H3,(H2,32,37)(H,35,38)/t22-,24?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224030 (6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C3(CC3)c12 Show InChI InChI=1S/C29H32N4O5/c1-28(2,14-18-6-9-21(10-7-18)38-24-11-8-19(15-31-24)26(30)35)32-16-20(34)17-37-23-5-3-4-22-25(23)29(12-13-29)27(36)33-22/h3-11,15,20,32,34H,12-14,16-17H2,1-2H3,(H2,30,35)(H,33,36)/t20-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	35	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224031 (6-(4-(2-((S)-2-hydroxy-3-(3-isopropyl-2-oxoindolin...) Show SMILES CC(C)C1C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 |w:3.2| Show InChI InChI=1S/C30H36N4O5/c1-18(2)26-27-23(34-29(26)37)6-5-7-24(27)38-17-21(35)16-33-30(3,4)14-19-8-11-22(12-9-19)39-25-13-10-20(15-32-25)28(31)36/h5-13,15,18,21,26,33,35H,14,16-17H2,1-4H3,(H2,31,36)(H,34,37)/t21-,26?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224021 ((S)-6-(4-(2-(3-(3,3-dimethyl-2-oxoindolin-4-yloxy)...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C(C)(C)c12 Show InChI InChI=1S/C29H34N4O5/c1-28(2,14-18-8-11-21(12-9-18)38-24-13-10-19(15-31-24)26(30)35)32-16-20(34)17-37-23-7-5-6-22-25(23)29(3,4)27(36)33-22/h5-13,15,20,32,34H,14,16-17H2,1-4H3,(H2,30,35)(H,33,36)/t20-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224029 (6-(4-(2-((S)-3-(3-benzyl-2-oxoindolin-4-yloxy)-2-h...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C(Cc3ccccc3)c12 |w:34.36| Show InChI InChI=1S/C34H36N4O5/c1-34(2,18-23-11-14-26(15-12-23)43-30-16-13-24(19-36-30)32(35)40)37-20-25(39)21-42-29-10-6-9-28-31(29)27(33(41)38-28)17-22-7-4-3-5-8-22/h3-16,19,25,27,37,39H,17-18,20-21H2,1-2H3,(H2,35,40)(H,38,41)/t25-,27?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224026 ((S)-6-(4-(2-(2-hydroxy-3-(2-oxoindolin-4-yloxy)pro...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)Cc12 Show InChI InChI=1S/C27H30N4O5/c1-27(2,30-15-19(32)16-35-23-5-3-4-22-21(23)12-24(33)31-22)13-17-6-9-20(10-7-17)36-25-11-8-18(14-29-25)26(28)34/h3-11,14,19,30,32H,12-13,15-16H2,1-2H3,(H2,28,34)(H,31,33)/t19-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224025 (6-(4-(2-((S)-2-hydroxy-3-(3-methyl-2-oxoindolin-4-...) Show SMILES CC1C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 |w:1.0| Show InChI InChI=1S/C28H32N4O5/c1-17-25-22(32-27(17)35)5-4-6-23(25)36-16-20(33)15-31-28(2,3)13-18-7-10-21(11-8-18)37-24-12-9-19(14-30-24)26(29)34/h4-12,14,17,20,31,33H,13,15-16H2,1-3H3,(H2,29,34)(H,32,35)/t17?,20-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224027 ((S)-6-(4-(2-(3-(3,3-dibenzyl-2-oxoindolin-4-yloxy)...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C(Cc3ccccc3)(Cc3ccccc3)c12 Show InChI InChI=1S/C41H42N4O5/c1-40(2,22-30-16-19-33(20-17-30)50-36-21-18-31(25-43-36)38(42)47)44-26-32(46)27-49-35-15-9-14-34-37(35)41(39(48)45-34,23-28-10-5-3-6-11-28)24-29-12-7-4-8-13-29/h3-21,25,32,44,46H,22-24,26-27H2,1-2H3,(H2,42,47)(H,45,48)/t32-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224022 (6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C3(CCCCC3)c12 Show InChI InChI=1S/C32H38N4O5/c1-31(2,17-21-9-12-24(13-10-21)41-27-14-11-22(18-34-27)29(33)38)35-19-23(37)20-40-26-8-6-7-25-28(26)32(30(39)36-25)15-4-3-5-16-32/h6-14,18,23,35,37H,3-5,15-17,19-20H2,1-2H3,(H2,33,38)(H,36,39)/t23-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224023 ((S)-6-(4-(2-(3-(3,3-diethyl-2-oxoindolin-4-yloxy)-...) Show SMILES CCC1(CC)C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 Show InChI InChI=1S/C31H38N4O5/c1-5-31(6-2)27-24(35-29(31)38)8-7-9-25(27)39-19-22(36)18-34-30(3,4)16-20-10-13-23(14-11-20)40-26-15-12-21(17-33-26)28(32)37/h7-15,17,22,34,36H,5-6,16,18-19H2,1-4H3,(H2,32,37)(H,35,38)/t22-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224028 (6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C3(CCC3)c12 Show InChI InChI=1S/C30H34N4O5/c1-29(2,15-19-7-10-22(11-8-19)39-25-12-9-20(16-32-25)27(31)36)33-17-21(35)18-38-24-6-3-5-23-26(24)30(13-4-14-30)28(37)34-23/h3,5-12,16,21,33,35H,4,13-15,17-18H2,1-2H3,(H2,31,36)(H,34,37)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50224032 (6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C3(CCCC3)c12 Show InChI InChI=1S/C31H36N4O5/c1-30(2,16-20-8-11-23(12-9-20)40-26-13-10-21(17-33-26)28(32)37)34-18-22(36)19-39-25-7-5-6-24-27(25)31(29(38)35-24)14-3-4-15-31/h5-13,17,22,34,36H,3-4,14-16,18-19H2,1-2H3,(H2,32,37)(H,35,38)/t22-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-2 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50193801 ((S)-6-(4-(2-(3-(3-(2-cyclopentylethyl)-2-oxo-2,3-d...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CCCC3)c12 Show InChI InChI=1S/C33H41N5O5/c1-33(2,18-23-10-13-26(14-11-23)43-29-15-12-24(19-35-29)31(34)40)36-20-25(39)21-42-28-9-5-8-27-30(28)38(32(41)37-27)17-16-22-6-3-4-7-22/h5,8-15,19,22,25,36,39H,3-4,6-7,16-18,20-21H2,1-2H3,(H2,34,40)(H,37,41)/t25-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	12	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta3 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50193802 ((S)-6-(4-(2-(3-(3-ethyl-2-oxo-2,3-dihydro-1H-benzo...) Show SMILES CCn1c2c(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)cccc2[nH]c1=O Show InChI InChI=1S/C28H33N5O5/c1-4-33-25-22(32-27(33)36)6-5-7-23(25)37-17-20(34)16-31-28(2,3)14-18-8-11-21(12-9-18)38-24-13-10-19(15-30-24)26(29)35/h5-13,15,20,31,34H,4,14,16-17H2,1-3H3,(H2,29,35)(H,32,36)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Rattus norvegicus)	BDBM50193803 ((S)-6-(4-(2-(2-hydroxy-3-(3-methyl-2-oxo-2,3-dihyd...) Show SMILES Cn1c2c(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)cccc2[nH]c1=O Show InChI InChI=1S/C27H31N5O5/c1-27(2,13-17-7-10-20(11-8-17)37-23-12-9-18(14-29-23)25(28)34)30-15-19(33)16-36-22-6-4-5-21-24(22)32(3)26(35)31-21/h4-12,14,19,30,33H,13,15-16H2,1-3H3,(H2,28,34)(H,31,35)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	25	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at rat beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50193804 ((S)-6-(4-(2-(3-(3-(2-cyclobutylethyl)-2-oxo-2,3-di...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CCC3)c12 Show InChI InChI=1S/C32H39N5O5/c1-32(2,17-22-9-12-25(13-10-22)42-28-14-11-23(18-34-28)30(33)39)35-19-24(38)20-41-27-8-4-7-26-29(27)37(31(40)36-26)16-15-21-5-3-6-21/h4,7-14,18,21,24,35,38H,3,5-6,15-17,19-20H2,1-2H3,(H2,33,39)(H,36,40)/t24-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	10	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta3 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50193803 ((S)-6-(4-(2-(2-hydroxy-3-(3-methyl-2-oxo-2,3-dihyd...) Show SMILES Cn1c2c(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)cccc2[nH]c1=O Show InChI InChI=1S/C27H31N5O5/c1-27(2,13-17-7-10-20(11-8-17)37-23-12-9-18(14-29-23)25(28)34)30-15-19(33)16-36-22-6-4-5-21-24(22)32(3)26(35)31-21/h4-12,14,19,30,33H,13,15-16H2,1-3H3,(H2,28,34)(H,31,35)/t19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	7.10	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta3 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Rattus norvegicus)	BDBM50193805 ((S)-6-(4-(2-(3-(3-(2-cyclopropylethyl)-2-oxo-2,3-d...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CC3)c12 Show InChI InChI=1S/C31H37N5O5/c1-31(2,16-21-8-11-24(12-9-21)41-27-13-10-22(17-33-27)29(32)38)34-18-23(37)19-40-26-5-3-4-25-28(26)36(30(39)35-25)15-14-20-6-7-20/h3-5,8-13,17,20,23,34,37H,6-7,14-16,18-19H2,1-2H3,(H2,32,38)(H,35,39)/t23-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	6.80	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at rat beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50193801 ((S)-6-(4-(2-(3-(3-(2-cyclopentylethyl)-2-oxo-2,3-d...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CCCC3)c12 Show InChI InChI=1S/C33H41N5O5/c1-33(2,18-23-10-13-26(14-11-23)43-29-15-12-24(19-35-29)31(34)40)36-20-25(39)21-42-28-9-5-8-27-30(28)38(32(41)37-27)17-16-22-6-3-4-7-22/h5,8-15,19,22,25,36,39H,3-4,6-7,16-18,20-21H2,1-2H3,(H2,34,40)(H,37,41)/t25-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50193802 ((S)-6-(4-(2-(3-(3-ethyl-2-oxo-2,3-dihydro-1H-benzo...) Show SMILES CCn1c2c(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)cccc2[nH]c1=O Show InChI InChI=1S/C28H33N5O5/c1-4-33-25-22(32-27(33)36)6-5-7-23(25)37-17-20(34)16-31-28(2,3)14-18-8-11-21(12-9-18)38-24-13-10-19(15-30-24)26(29)35/h5-13,15,20,31,34H,4,14,16-17H2,1-3H3,(H2,29,35)(H,32,36)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	5.20	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta3 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50224030 (6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C3(CC3)c12 Show InChI InChI=1S/C29H32N4O5/c1-28(2,14-18-6-9-21(10-7-18)38-24-11-8-19(15-31-24)26(30)35)32-16-20(34)17-37-23-5-3-4-22-25(23)29(12-13-29)27(36)33-22/h3-11,15,20,32,34H,12-14,16-17H2,1-2H3,(H2,30,35)(H,33,36)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	58	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50193805 ((S)-6-(4-(2-(3-(3-(2-cyclopropylethyl)-2-oxo-2,3-d...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CC3)c12 Show InChI InChI=1S/C31H37N5O5/c1-31(2,16-21-8-11-24(12-9-21)41-27-13-10-22(17-33-27)29(32)38)34-18-23(37)19-40-26-5-3-4-25-28(26)36(30(39)35-25)15-14-20-6-7-20/h3-5,8-13,17,20,23,34,37H,6-7,14-16,18-19H2,1-2H3,(H2,32,38)(H,35,39)/t23-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50193803 ((S)-6-(4-(2-(2-hydroxy-3-(3-methyl-2-oxo-2,3-dihyd...) Show SMILES Cn1c2c(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)cccc2[nH]c1=O Show InChI InChI=1S/C27H31N5O5/c1-27(2,13-17-7-10-20(11-8-17)37-23-12-9-18(14-29-23)25(28)34)30-15-19(33)16-36-22-6-4-5-21-24(22)32(3)26(35)31-21/h4-12,14,19,30,33H,13,15-16H2,1-3H3,(H2,28,34)(H,31,35)/t19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	8.70	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50193804 ((S)-6-(4-(2-(3-(3-(2-cyclobutylethyl)-2-oxo-2,3-di...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CCC3)c12 Show InChI InChI=1S/C32H39N5O5/c1-32(2,17-22-9-12-25(13-10-22)42-28-14-11-23(18-34-28)30(33)39)35-19-24(38)20-41-27-8-4-7-26-29(27)37(31(40)36-26)16-15-21-5-3-6-21/h4,7-14,18,21,24,35,38H,3,5-6,15-17,19-20H2,1-2H3,(H2,33,39)(H,36,40)/t24-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50193806 ((S)-6-(4-(2-(2-hydroxy-3-(2-oxo-3-propyl-2,3-dihyd...) Show SMILES CCCn1c2c(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)cccc2[nH]c1=O Show InChI InChI=1S/C29H35N5O5/c1-4-14-34-26-23(33-28(34)37)6-5-7-24(26)38-18-21(35)17-32-29(2,3)15-19-8-11-22(12-9-19)39-25-13-10-20(16-31-25)27(30)36/h5-13,16,21,32,35H,4,14-15,17-18H2,1-3H3,(H2,30,36)(H,33,37)/t21-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50193805 ((S)-6-(4-(2-(3-(3-(2-cyclopropylethyl)-2-oxo-2,3-d...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CC3)c12 Show InChI InChI=1S/C31H37N5O5/c1-31(2,16-21-8-11-24(12-9-21)41-27-13-10-22(17-33-27)29(32)38)34-18-23(37)19-40-26-5-3-4-25-28(26)36(30(39)35-25)15-14-20-6-7-20/h3-5,8-13,17,20,23,34,37H,6-7,14-16,18-19H2,1-2H3,(H2,32,38)(H,35,39)/t23-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	5.40	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta3 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Rattus norvegicus)	BDBM50193804 ((S)-6-(4-(2-(3-(3-(2-cyclobutylethyl)-2-oxo-2,3-di...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2[nH]c(=O)n(CCC3CCC3)c12 Show InChI InChI=1S/C32H39N5O5/c1-32(2,17-22-9-12-25(13-10-22)42-28-14-11-23(18-34-28)30(33)39)35-19-24(38)20-41-27-8-4-7-26-29(27)37(31(40)36-26)16-15-21-5-3-6-21/h4,7-14,18,21,24,35,38H,3,5-6,15-17,19-20H2,1-2H3,(H2,33,39)(H,36,40)/t24-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	29	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at rat beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP levels				Bioorg Med Chem Lett 16: 5691-4 (2006) Article DOI: 10.1016/j.bmcl.2006.08.010 BindingDB Entry DOI: 10.7270/Q2251HVR
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224023 ((S)-6-(4-(2-(3-(3,3-diethyl-2-oxoindolin-4-yloxy)-...) Show SMILES CCC1(CC)C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 Show InChI InChI=1S/C31H38N4O5/c1-5-31(6-2)27-24(35-29(31)38)8-7-9-25(27)39-19-22(36)18-34-30(3,4)16-20-10-13-23(14-11-20)40-26-15-12-21(17-33-26)28(32)37/h7-15,17,22,34,36H,5-6,16,18-19H2,1-4H3,(H2,32,37)(H,35,38)/t22-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	2.70	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224025 (6-(4-(2-((S)-2-hydroxy-3-(3-methyl-2-oxoindolin-4-...) Show SMILES CC1C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 |w:1.0| Show InChI InChI=1S/C28H32N4O5/c1-17-25-22(32-27(17)35)5-4-6-23(25)36-16-20(33)15-31-28(2,3)13-18-7-10-21(11-8-18)37-24-12-9-19(14-30-24)26(29)34/h4-12,14,17,20,31,33H,13,15-16H2,1-3H3,(H2,29,34)(H,32,35)/t17?,20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	12	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224024 (6-(4-(2-((S)-2-hydroxy-3-(3-isobutyl-2-oxoindolin-...) Show SMILES CC(C)CC1C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 |w:4.3| Show InChI InChI=1S/C31H38N4O5/c1-19(2)14-24-28-25(35-30(24)38)6-5-7-26(28)39-18-22(36)17-34-31(3,4)15-20-8-11-23(12-9-20)40-27-13-10-21(16-33-27)29(32)37/h5-13,16,19,22,24,34,36H,14-15,17-18H2,1-4H3,(H2,32,37)(H,35,38)/t22-,24?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	14	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224027 ((S)-6-(4-(2-(3-(3,3-dibenzyl-2-oxoindolin-4-yloxy)...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C(Cc3ccccc3)(Cc3ccccc3)c12 Show InChI InChI=1S/C41H42N4O5/c1-40(2,22-30-16-19-33(20-17-30)50-36-21-18-31(25-43-36)38(42)47)44-26-32(46)27-49-35-15-9-14-34-37(35)41(39(48)45-34,23-28-10-5-3-6-11-28)24-29-12-7-4-8-13-29/h3-21,25,32,44,46H,22-24,26-27H2,1-2H3,(H2,42,47)(H,45,48)/t32-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	268	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50224024 (6-(4-(2-((S)-2-hydroxy-3-(3-isobutyl-2-oxoindolin-...) Show SMILES CC(C)CC1C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 |w:4.3| Show InChI InChI=1S/C31H38N4O5/c1-19(2)14-24-28-25(35-30(24)38)6-5-7-26(28)39-18-22(36)17-34-31(3,4)15-20-8-11-23(12-9-20)40-27-13-10-21(16-33-27)29(32)37/h5-13,16,19,22,24,34,36H,14-15,17-18H2,1-4H3,(H2,32,37)(H,35,38)/t22-,24?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224029 (6-(4-(2-((S)-3-(3-benzyl-2-oxoindolin-4-yloxy)-2-h...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C(Cc3ccccc3)c12 |w:34.36| Show InChI InChI=1S/C34H36N4O5/c1-34(2,18-23-11-14-26(15-12-23)43-30-16-13-24(19-36-30)32(35)40)37-20-25(39)21-42-29-10-6-9-28-31(29)27(33(41)38-28)17-22-7-4-3-5-8-22/h3-16,19,25,27,37,39H,17-18,20-21H2,1-2H3,(H2,35,40)(H,38,41)/t25-,27?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	12	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224030 (6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C3(CC3)c12 Show InChI InChI=1S/C29H32N4O5/c1-28(2,14-18-6-9-21(10-7-18)38-24-11-8-19(15-31-24)26(30)35)32-16-20(34)17-37-23-5-3-4-22-25(23)29(12-13-29)27(36)33-22/h3-11,15,20,32,34H,12-14,16-17H2,1-2H3,(H2,30,35)(H,33,36)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	6.60	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50224022 (6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C3(CCCCC3)c12 Show InChI InChI=1S/C32H38N4O5/c1-31(2,17-21-9-12-24(13-10-21)41-27-14-11-22(18-34-27)29(33)38)35-19-23(37)20-40-26-8-6-7-25-28(26)32(30(39)36-25)15-4-3-5-16-32/h6-14,18,23,35,37H,3-5,15-17,19-20H2,1-2H3,(H2,33,38)(H,36,39)/t23-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50224031 (6-(4-(2-((S)-2-hydroxy-3-(3-isopropyl-2-oxoindolin...) Show SMILES CC(C)C1C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 |w:3.2| Show InChI InChI=1S/C30H36N4O5/c1-18(2)26-27-23(34-29(26)37)6-5-7-24(27)38-17-21(35)16-33-30(3,4)14-19-8-11-22(12-9-19)39-25-13-10-20(15-32-25)28(31)36/h5-13,15,18,21,26,33,35H,14,16-17H2,1-4H3,(H2,31,36)(H,34,37)/t21-,26?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224022 (6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C3(CCCCC3)c12 Show InChI InChI=1S/C32H38N4O5/c1-31(2,17-21-9-12-24(13-10-21)41-27-14-11-22(18-34-27)29(33)38)35-19-23(37)20-40-26-8-6-7-25-28(26)32(30(39)36-25)15-4-3-5-16-32/h6-14,18,23,35,37H,3-5,15-17,19-20H2,1-2H3,(H2,33,38)(H,36,39)/t23-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	8.30	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224031 (6-(4-(2-((S)-2-hydroxy-3-(3-isopropyl-2-oxoindolin...) Show SMILES CC(C)C1C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 |w:3.2| Show InChI InChI=1S/C30H36N4O5/c1-18(2)26-27-23(34-29(26)37)6-5-7-24(27)38-17-21(35)16-33-30(3,4)14-19-8-11-22(12-9-19)39-25-13-10-20(15-32-25)28(31)36/h5-13,15,18,21,26,33,35H,14,16-17H2,1-4H3,(H2,31,36)(H,34,37)/t21-,26?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	14	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224021 ((S)-6-(4-(2-(3-(3,3-dimethyl-2-oxoindolin-4-yloxy)...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C(C)(C)c12 Show InChI InChI=1S/C29H34N4O5/c1-28(2,14-18-8-11-21(12-9-18)38-24-13-10-19(15-31-24)26(30)35)32-16-20(34)17-37-23-7-5-6-22-25(23)29(3,4)27(36)33-22/h5-13,15,20,32,34H,14,16-17H2,1-4H3,(H2,30,35)(H,33,36)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	5.20	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224026 ((S)-6-(4-(2-(2-hydroxy-3-(2-oxoindolin-4-yloxy)pro...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)Cc12 Show InChI InChI=1S/C27H30N4O5/c1-27(2,30-15-19(32)16-35-23-5-3-4-22-21(23)12-24(33)31-22)13-17-6-9-20(10-7-17)36-25-11-8-18(14-29-25)26(28)34/h3-11,14,19,30,32H,12-13,15-16H2,1-2H3,(H2,28,34)(H,31,33)/t19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	24	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50224023 ((S)-6-(4-(2-(3-(3,3-diethyl-2-oxoindolin-4-yloxy)-...) Show SMILES CCC1(CC)C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 Show InChI InChI=1S/C31H38N4O5/c1-5-31(6-2)27-24(35-29(31)38)8-7-9-25(27)39-19-22(36)18-34-30(3,4)16-20-10-13-23(14-11-20)40-26-15-12-21(17-33-26)28(32)37/h7-15,17,22,34,36H,5-6,16,18-19H2,1-4H3,(H2,32,37)(H,35,38)/t22-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50224025 (6-(4-(2-((S)-2-hydroxy-3-(3-methyl-2-oxoindolin-4-...) Show SMILES CC1C(=O)Nc2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(cn4)C(N)=O)cc3)c12 |w:1.0| Show InChI InChI=1S/C28H32N4O5/c1-17-25-22(32-27(17)35)5-4-6-23(25)36-16-20(33)15-31-28(2,3)13-18-7-10-21(11-8-18)37-24-12-9-19(14-30-24)26(29)34/h4-12,14,17,20,31,33H,13,15-16H2,1-3H3,(H2,29,34)(H,32,35)/t17?,20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-3 adrenergic receptor (Homo sapiens (Human))	BDBM50224032 (6-[4-(2-{[(2S)-2-hydroxy-3-{2'-oxo-1',2'-dihydrosp...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C3(CCCC3)c12 Show InChI InChI=1S/C31H36N4O5/c1-30(2,16-20-8-11-23(12-9-20)40-26-13-10-21(17-33-26)28(32)37)34-18-22(36)19-39-25-7-5-6-24-27(25)31(29(38)35-24)14-3-4-15-31/h5-13,17,22,34,36H,3-4,14-16,18-19H2,1-2H3,(H2,32,37)(H,35,38)/t22-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	11	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-3 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50224027 ((S)-6-(4-(2-(3-(3,3-dibenzyl-2-oxoindolin-4-yloxy)...) Show SMILES CC(C)(Cc1ccc(Oc2ccc(cn2)C(N)=O)cc1)NC[C@H](O)COc1cccc2NC(=O)C(Cc3ccccc3)(Cc3ccccc3)c12 Show InChI InChI=1S/C41H42N4O5/c1-40(2,22-30-16-19-33(20-17-30)50-36-21-18-31(25-43-36)38(42)47)44-26-32(46)27-49-35-15-9-14-34-37(35)41(39(48)45-34,23-28-10-5-3-6-11-28)24-29-12-7-4-8-13-29/h3-21,25,32,44,46H,22-24,26-27H2,1-2H3,(H2,42,47)(H,45,48)/t32-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Lilly Research Laboratories Curated by ChEMBL					Assay Description Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level				Bioorg Med Chem Lett 17: 6270-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.011 BindingDB Entry DOI: 10.7270/Q22V2FV6
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 62 total )  |  Next  |  Last  >>

Jump to: